Early buyers will receive 10% customization on this report.
Sleep apnea is the most common sleep disorder that usually goes undiagnosed; however, it has serious and life-threatening effects. This disorder involves abnormal pauses in breathing, which range from a few seconds to minutes, or occurrence of abnormally low breathing during sleep.
Growing awareness regarding the ill effects of sleep apnea in North America, growing usage of oral appliances for sleep apnea treatment, and the large pool of undiagnosed and untreated sleep apnea patients are major factors driving the growth of the market. Technological advancements in sleep apnea devices are also supporting the growth of sleep apnea market.
• To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges).
• To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market.
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
• To forecast the size of the sleep apnea devices market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World.
• To strategically profile the key players in the global sleep apnea devices market and comprehensively analyze their core competencies.
• To track and analyze competitive developments such as joint ventures and alliances, mergers and acquisitions, new product/technology development, and research and development activities of the leading players in the global Sleep Apnea Devices market.
The prominent players in the global sleep apnea devices market include ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand).
These companies are dominant in the market mainly due to their well-established presence in the field of sleep apnea devices, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.), BMC Medical Co., Ltd. (China) and DeVilbiss Healthcare (U.S.), and Braebon Medical Corporation (Canada).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: